← back to search

Miaojia Zhang

Nantong University · CN
Area of research
Rheumatology · Pathology and Forensic Medicine
Research interest
Research focused on Systemic lupus erythematosus and Dermatomyositis, with related work in Interstitial lung disease, Immunology, Proportional hazards model. Notable publications include 'Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study', 'Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial', and 'Identification of Three Different Phenotypes in Anti–Melanoma Differentiation–Associated Gene 5 Antibody–Positive Dermatomyositis Patients: Implications for Prediction of Rapidly...'.
h-index
citations
770
works
18
NIH funding
primary concept
email

Recent publications

Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model
Frontiers in Immunology 2024cited by 24position: middledoi
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial
Annals of the Rheumatic Diseases 2023cited by 134position: middledoi
Latent Tuberculosis Infection and Associated Factors in Patients with Systemic Lupus Erythematosus: a Multicenter, Cross-Sectional Study
Microbiology Spectrum 2023cited by 12position: middledoi
Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosus
RMD Open 2023cited by 10position: middledoi
Improve quality of patient care for systemic lupus erythematosus in China by enhancing the construction of Centers of Excellence
Rheumatology and Immunology Research 2023cited by 4position: middledoi
Identification of Three Different Phenotypes in Anti–Melanoma Differentiation–Associated Gene 5 Antibody–Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease
Arthritis & Rheumatology 2022cited by 93position: middledoi
Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody–Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk
The Journal of Rheumatology 2022cited by 55position: middledoi
Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China
Lara D. Veeken 2022cited by 47position: middledoi
Loss-of-function variants in SAT1 cause X-linked childhood-onset systemic lupus erythematosus
Annals of the Rheumatic Diseases 2022cited by 29position: middledoi
Clinical and laboratorial outcome of different age-onset systemic lupus erythematosus patients in Jiangsu, China: a multicentre retrospective study
Scientific Reports 2022cited by 17position: middledoi
Renal tubular acidosis and associated factors in patients with primary Sjögren’s syndrome: a registry-based study
Clinical Rheumatology 2022cited by 10position: middledoi
Human SLE variant NCF1-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages
Annals of the Rheumatic Diseases 2021cited by 45position: middledoi
The relationship of polluted air and drinking water sources with the prevalence of systemic lupus erythematosus: a provincial population-based study
Scientific Reports 2021cited by 11position: middledoi
Association of antimalarial drugs with decreased overall and cause specific mortality in systemic lupus erythematosus
Lara D. Veeken 2020cited by 21position: middledoi
Clinical analysis of macrophage activation syndrome in adult rheumatic disease: A multicenter retrospective study
International Journal of Rheumatic Diseases 2020cited by 15position: middledoi
Creatinine clearance rate predicts prognosis of patients with systemic lupus erythematosus: a large retrospective cohort study
Clinical Rheumatology 2020cited by 14position: middledoi
Protective effects of antimalarials in Chinese patients with systemic lupus erythematosus
Annals of the Rheumatic Diseases 2018cited by 13position: middledoi
Chinese SLE Treatment and Research Group (CSTAR) registry:VIII. Influence of socioeconomic and geographical variables on disease phenotype and activity in Chinese patients with <scp>SLE</scp>
International Journal of Rheumatic Diseases 2017cited by 29position: middledoi
Prognosis for Hospitalized Patients with Systemic Lupus Erythematosus in China: 5-Year Update of the Jiangsu Cohort
PLoS ONE 2016cited by 36position: middledoi
Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study
Arthritis Research & Therapy 2014cited by 314position: middledoi
Chinese SLE Treatment and Research Group Registry: III. Association of Autoantibodies with Clinical Manifestations in Chinese Patients with Systemic Lupus Erythematosus
Journal of Immunology Research 2014cited by 54position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xuebing Feng · Nanjing University of Chinese Medicine7 papers (2016–2023)Jian Wu · Nantong University6 papers (2016–2022)Zhanyun Da · Nantong University6 papers (2016–2022)Wei Hua · Sichuan University6 papers (2016–2022)Lingyun Sun · Nanjing University of Chinese Medicine6 papers (2014–2021) · 5 papers (2016–2022) · 5 papers (2016–2022)Jiuliang Zhao · Ministry of Education of the People's Republic of China5 papers (2014–2023)Mengtao Li · Ministry of Education of the People's Republic of China5 papers (2014–2023)Min Wu · University of Minnesota5 papers (2016–2022)Juan Tao · Palo Alto University5 papers (2016–2022)Wenyou Pan · Xuzhou Medical College5 papers (2016–2022)Yaohong Zou · Nanjing Medical University5 papers (2016–2022)Xian Qian · Second Military Medical University5 papers (2016–2022)Wenfeng Tan · Nantong University4 papers (2020–2023)Ziyi Jin · Jiangsu University4 papers (2020–2023)Meimei Wang · Guangdong University of Technology4 papers (2016–2022)Xiang Ding · New York University4 papers (2016–2022)Xiaofeng Zeng · Ministry of Education of the People's Republic of China4 papers (2014–2023)Xinwang Duan · Nanchang University3 papers (2022–2023)